
What to Expect at Your First Psilocybin Therapy Session
Before you are accepted
Every legitimate program starts with screening. Expect a detailed medical and psychiatric history, a review of your medications, and questions about your goals. People with a personal or family history of psychosis are typically excluded, and some antidepressants may need to be tapered under medical supervision.
Preparation sessions
You will meet your facilitators — usually two — at least once or twice before dosing day. These meetings cover what the experience can feel like, how to handle difficult moments, and practical details like what to wear and eat. The FDA's guidance on psychedelic clinical trials emphasizes this kind of structured support as a core safety feature.
The dosing room
Dosing rooms in trials and licensed programs look more like a calm living room than a hospital: a couch or recliner, soft lighting, blankets, eyeshades and headphones with a curated music playlist. After you take the capsule, effects begin within 20 to 40 minutes and the peak lasts two to three hours.
What the experience feels like
Participants commonly report vivid imagery, strong emotions, a softened sense of self and a feeling of insight or perspective. Difficult stretches — anxiety, grief, physical unease — are normal and expected. Your facilitators stay in the room the entire time; their job is reassurance, not direction.
Afterward: integration
The session itself is only part of the treatment. In the days and weeks that follow, integration sessions help you make sense of what came up and translate it into changes in daily life. Researchers increasingly credit this follow-up work with much of the lasting benefit.
Practical tips
- Clear your schedule for the full day and the morning after.
- Arrange a ride home; you cannot drive after a session.
- Avoid alcohol and recreational drugs in the days before.
- Bring an open mind rather than a fixed expectation.
Written by
Psilocybin News Editorial Team
The Psilocybin News editorial team covers psychedelic science, clinical research and policy, translating peer-reviewed evidence into clear, accurate reporting for patients, families and professionals.
PreviousAntidepressants and Psilocybin Trials: Why Medication Changes Need Medical Oversight
NextResponse, Remission, Relapse: Decoding Psilocybin Depression Results


